RAPT NASDAQ
RAPT Therapeutics, Inc.
1W: +0.1%
1M: +0.4%
3M: +80.8%
YTD: +82.1%
1Y: +541.7%
3Y: -75.7%
5Y: -61.3%
$58.01
Last traded 2026-03-06 — delisted
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
📊 Key Metrics
TTM$0M
Revenue
+0.0% YoY
$-106M
Net Income
+1.7% YoY
$-87M
Free Cash Flow
+14.0% YoY
0.0%
Gross Margin
0.0%
Op. Margin
0.0%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
⚠️ Cash Burn Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE-85.4%
ROA-77.0%
ROIC3211.2%
Valuation
P/E-44.5
P/B10.3
EV/EBITDA-5.0
Leverage
Debt/Equity0.02
Current Ratio12.04
Interest Cov.0.0x
Quality Scores
Piotroski F4/9
Altman Z23.58
Beneish M0.00